Early complement genes are associated with visual system degeneration in multiple sclerosis
The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Multiple sclerosis is a heterogeneous disease with an unpredictable course and a wide range of severity; some individuals rapidly progress to a disabled state whereas others experience only mild symptoms. Though genetic studies have identified variants that are associated with an increased risk of developing multiple sclerosis, no variants have been consistently associated with multiple sclerosis severity. In part, the lack of findings is related to inherent limitations of clinical rating scales; these scales are insensitive to early degenerative changes that underlie disease progression. Optical coherence tomography imaging of the retina and low-contrast letter acuity correlate with and predict clinical and imaging-based outcomes in multiple sclerosis. Therefore, they may serve as sensitive phenotypes to discover genetic predictors of disease course. We conducted a set of genome-wide association studies of longitudinal structural and functional visual pathway phenotypes in multiple sclerosis. First, we assessed genetic predictors of ganglion cell/inner plexiform layer atrophy in a discovery cohort of 374 patients with multiple sclerosis using mixed-effects models adjusting for age, sex, disease duration, optic neuritis and genetic ancestry and using a combination of single-variant and network-based analyses. For candidate variants identified in discovery, we conducted a similar set of analyses of ganglion cell/inner plexiform layer thinning in a replication cohort (n = 376). Second, we assessed genetic predictors of sustained loss of 5-letters in low-contrast letter acuity in discovery (n = 582) using multivariable-adjusted Cox proportional hazards models. We then evaluated candidate variants/pathways in a replication cohort. (n = 253). Results of both studies revealed novel subnetworks highly enriched for connected genes in early complement activation linked to measures of disease severity. Within these networks, C3 was the gene most strongly associated with ganglion cell/inner plexiform layer atrophy (P = 0.004) and C1QA and CR1 were top results in analysis of sustained low-contrast letter acuity loss. Namely, variant rs158772, linked to C1QA, and rs61822967, linked to CR1, were associated with 71% and 40% increases in risk of sustained LCLA loss, respectively, in meta-analysis pooling discovery and replication cohorts (rs158772: hazard ratio: 1.71; 95% confidence interval 1.30–2.25; P = 1.3 × 10−4; rs61822967: hazard ratio: 1.40; 95% confidence interval: 1.16–1.68; P = 4.1 × 10−4). In conclusion, early complement pathway gene variants were consistently associated with structural and functional measures of multiple sclerosis severity. These results from unbiased analyses are strongly supported by several prior reports that mechanistically implicated early complement factors in neurodegeneration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A standard GWAS quality control pipeline was implemented as previously described.34”
From A lymphocyte–microglia–astrocyte axis in chronic active multiple sclerosis (2021) · cites this paper as [34]
In the citing paper
“Cases harbouring >4 PRL — an identified clinically relevant threshold4 — had more complement-associated risk variants than those with fewer or no PRL (ANOVA p=0.04, Tukey’s multiple comparison test p=0.035, Fig.3g)”
From A lymphocyte–microglia–astrocyte axis in chronic active multiple sclerosis (2021) · cites this paper as [34]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neurotoxic reactive astrocytes are induced by activated microglia
Liddelow, S. A., Guttenplan, K. A., Clarke, L. E., Bennett, F. C., Bohlen, C. J., Schirmer, L., Bennett, M. L., Münch, A. E., Chung, W.-S., Peterson, T. C., et al. (2017) · Nature · doi:10.1038/nature21029 · Cited by 7,971
Functional mapping and annotation of genetic associations with FUMA
Watanabe, K., Taskesen, E., van Bochoven, A., & Posthuma, D. (2017) · Nature Communications · doi:10.1038/s41467-017-01261-5 · Cited by 4,083
Next-generation genotype imputation service and methods
Das, S., Forer, L., Schönherr, S., Sidore, C., Locke, A. E., Kwong, A., Vrieze, S. I., Chew, E. Y., Levy, S., McGue, M., et al. (2016) · Nature Genetics · doi:10.1038/ng.3656 · Cited by 3,808
MAGMA: Generalized Gene-Set Analysis of GWAS Data
de Leeuw, C. A., Mooij, J. M., Heskes, T., & Posthuma, D. (2015) · PLOS Computational Biology · doi:10.1371/journal.pcbi.1004219 · Cited by 3,653
Complement and microglia mediate early synapse loss in Alzheimer mouse models
Hong, S., Beja-Glasser, V. F., Nfonoyim, B. M., Frouin, A., Li, S., Ramakrishnan, S., Merry, K. M., Shi, Q., Rosenthal, A., Barres, B. A., et al. (2016) · Science · doi:10.1126/science.aad8373 · Cited by 3,343
A reference panel of 64,976 haplotypes for genotype imputation
the Haplotype Reference Consortium (2016) · Nature Genetics · doi:10.1038/ng.3643 · Cited by 2,836
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
The International Multiple Sclerosis Genetics Consortium & The Wellcome Trust Case Control Consortium 2 (2011) · Nature · doi:10.1038/nature10251 · Cited by 2,697
Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility
International Multiple Sclerosis Genetics Consortium, Patsopoulos, N. A., Baranzini, S. E., Santaniello, A., Shoostari, P., Cotsapas, C., Wong, G., Beecham, A. H., James, T., Replogle, J., et al. (2019) · Science · doi:10.1126/science.aav7188 · Cited by 1,818
Self-citationFast and accurate genotype imputation in genome-wide association studies through pre-phasing
Howie, B., Fuchsberger, C., Stephens, M., Marchini, J., & Abecasis, G. R. (2012) · Nature Genetics · doi:10.1038/ng.2354 · Cited by 1,737
The OSCAR-IB Consensus Criteria for Retinal OCT Quality Assessment
Tewarie, P., Balk, L., Costello, F., Green, A., Martin, R., Schippling, S., & Petzold, A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034823 · Cited by 627
Self-citation
Research works printed but not linked: 44
- Balcer, 2012, Low-contrast acuity measures visual improvement in phase 3 trial of natalizumab in relapsing multiple sclerosis, J Neurol Sci, 318, 119, 10.1016/j.jns.2012.03.009 · DOI
- Balcer, 2017, Validity of low-contrast letter acuity as a visual performance outcome measure for multiple sclerosis, Mult Scler, 23, 734, 10.1177/1352458517690822 · DOI · Paper page
- Balk, 2016, Timing of retinal neuronal and axonal loss in multiple sclerosis: a longitudinal OCT study, J Neurol, 263, 1323, 10.1007/s00415-016-8127-y · DOI · Paper page
- Baranzini, 2009, Pathway and network-based analysis of genome-wide association studies in multiple sclerosis, Hum Mol Genet, 18, 2078, 10.1093/hmg/ddp120 · DOI · Paper page
- Baranzini, 2010, Genetic variation influences glutamate concentrations in brains of patients with multiple sclerosis, Brain, 133, 2603, 10.1093/brain/awq192 · DOI · Paper page
- Beck, 2007, Visual acuity as an outcome measure in clinical trials of retinal diseases, Ophthalmology, 114, 1804, 10.1016/j.ophtha.2007.06.047 · DOI · Paper page
- De Jager, 2012, A genome-wide scan for common variants affecting the rate of age-related cognitive decline, Neurobiol Aging, 33, 1017.e1, 10.1016/j.neurobiolaging.2011.09.033 · DOI · Paper page
- Estrada, 2018, A whole-genome sequence study identifies genetic risk factors for neuromyelitis optica, Nat Commun, 9, 1929, 10.1038/s41467-018-04332-3 · DOI
- Gourraud, 2013, A genome-wide association study of brain lesion distribution in multiple sclerosis, Brain, 136, 1012, 10.1093/brain/aws363 · DOI
- Housley, 2015, Genetic variants associated with autoimmunity drive NFκB signaling and responses to inflammatory stimuli, Sci Transl Med, 7, 291ra93, 10.1126/scitranslmed.aaa9223 · DOI
- Isobe, 2016, Association of HLA genetic risk burden with disease phenotypes in multiple sclerosis, JAMA Neurol, 73, 795, 10.1001/jamaneurol.2016.0980 · DOI
- Jager, 2009, Integration of genetic risk factors into a clinical algorithm for multiple sclerosis susceptibility: a weighted genetic risk score, Lancet Neurol, 8, 1111, 10.1016/S1474-4422(09)70275-3 · DOI · Paper page
- Jia, 2013, Imputing amino acid polymorphisms in human leukocyte antigens, PLoS One, 8, e64683, 10.1371/journal.pone.0064683 · DOI · Paper page
- Kamburov, 2013, The ConsensusPathDB interaction database: 2013 update, Nucleic Acids Res, 41, D793, 10.1093/nar/gks1055 · DOI · Paper page
- Katz, 2014, Musashi proteins are post-transcriptional regulators of the epithelial-luminal cell state, Elife, 3, e03915, 10.7554/eLife.03915 · DOI · Paper page
- Lambert, 2013, Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer’s disease, Nat Genet, 45, 1452, 10.1038/ng.2802 · DOI · Paper page
- Leiserson, 2015, Pan-cancer network analysis identifies combinations of rare somatic mutations across pathways and protein complexes, Nat. Genet, 47, 106, 10.1038/ng.3168 · DOI · Paper page
- Lindsey, 2012, The CombiRx trial of combined therapy with interferon and glatiramer cetate in relapsing remitting multiple sclerosis: design and baseline characteristics, Mult Scler Relat Disord, 1, 81, 10.1016/j.msard.2012.01.006 · DOI
- Lublin, 2013, Randomized study combining interferon & glatiramer acetate in multiple sclerosis, Ann Neurol, 73, 327, 10.1002/ana.23863 · DOI · Paper page
- Maghzi, 2014, Magnetic resonance imaging correlates of clinical outcomes in early multiple sclerosis, Mult Scler Relat Disord, 3, 720, 10.1016/j.msard.2014.07.003 · DOI
- Martinez-Lapiscina, 2016, Retinal thickness measured with optical coherence tomography and risk of disability worsening in multiple sclerosis: a cohort study, Lancet Neurol, 15, 574, 10.1016/S1474-4422(16)00068-5 · DOI · Paper page
- Matsushita, 2015, Genetic associations with brain cortical thickness in multiple sclerosis, Genes Brain Behav, 14, 217, 10.1111/gbb.12190 · DOI
- Michailidou, 2017, Complement C3 on microglial clusters in multiple sclerosis occur in chronic but not acute disease: implication for disease pathogenesis, Glia, 65, 264, 10.1002/glia.23090 · DOI · Paper page
- Michailidou, 2015, Complement C1q-C3-associated synaptic changes in multiple sclerosis hippocampus, Ann Neurol, 77, 1007, 10.1002/ana.24398 · DOI · Paper page
- Morgan, 2017, Molecular cell biology of complement membrane attack, Semin Cell Dev Biol, 72, 124, 10.1016/j.semcdb.2017.06.009 · doi:10.1016/j.semcdb.2017.06.009
- Murphy, 2016, The Musashi 1 controls the splicing of photoreceptor-specific exons in the vertebrate retina, PLoS Genet, 12, e1006256, 10.1371/journal.pgen.1006256 · DOI · Paper page
- Nakka, 2016, Gene and network analysis of common variants reveals novel associations in multiple complex diseases, Genetics, 204, 783, 10.1534/genetics.116.188391 · DOI
- Orsini, 2014, Versatility of the complement system in neuroinflammation, neurodegeneration and brain homeostasis, Front Cell Neurosci, 8, 380, 10.3389/fncel.2014.00380 · DOI · Paper page
- Reed, 2015, A guide to genome-wide association analysis and post-analytic interrogation, Stat Med, 34, 3769, 10.1002/sim.6605 · DOI
- Razick, 2008, iRefIndex: A consolidated protein interaction database with provenance, BMC Bioinform, 9, 405, 10.1186/1471-2105-9-405 · DOI · Paper page
- Roostaei, 2019, Convergent effects of a functional C3 variant on brain atrophy, demyelination, and cognitive impairment in multiple sclerosis, Mult Scler, 25, 532, 10.1177/1352458518760715 · DOI
- Saidha, 2015, Optical coherence tomography reflects brain atrophy in multiple sclerosis: a four-year study, Ann Neurol, 78, 801, 10.1002/ana.24487 · DOI · Paper page
- Scarr, 2016, Increased cortical expression of the zinc transporter SLC39A12 suggests a breakdown in zinc cellular homeostasis as part of the pathophysiology of schizophrenia, npj Schizophrenia, 2, 16002, 10.1038/npjschz.2016.2 · DOI · Paper page
- Scolding, 1998, The expression of complement regulatory proteins by adult human oligodendrocytes, J Neuroimmunol, 84, 69, 10.1016/S0165-5728(97)00241-5 · DOI
- Stevens, 2007, The classical complement cascade mediates CNS synapse elimination, Cell, 131, 1164, 10.1016/j.cell.2007.10.036 · DOI · Paper page
- Syc, 2012, Optical coherence tomography segmentation reveals ganglion cell layer pathology after optic neuritis, Brain, 135, 521, 10.1093/brain/awr264 · DOI · Paper page
- Talman, 2010, Longitudinal study of vision and retinal nerve fiber layer thickness in multiple sclerosis, Ann Neurol, 67, 749, 10.1002/ana.22005 · DOI · Paper page
- Trip, 2005, Retinal nerve fiber layer axonal loss and visual dysfunction in optic neuritis, Ann Neurol, 58, 383, 10.1002/ana.20575 · DOI · Paper page
- Vanderweele, 2014, Effect decomposition in the presence of an exposure-induced mediator-outcome confounder, Epidemiology, 25, 300, 10.1097/EDE.0000000000000034 · DOI · Paper page
- Verma, 2014, Imputation and quality control steps for combining multiple genome-wide datasets, Front Genet, 5, 370, 10.3389/fgene.2014.00370 · DOI · Paper page
- Watkins, 2016, Complement is activated in progressive multiple sclerosis cortical grey matter lesions, J Neuroinflamm, 13, 161, 10.1186/s12974-016-0611-x · DOI · Paper page
- Willer, 2010, METAL: fast and efficient meta-analysis of genomewide association scans, Bioinformatics, 26, 2190, 10.1093/bioinformatics/btq340 · DOI · Paper page
- Wing, 1999, Comparison of C1q-receptors on rat microglia and peritoneal macrophages, J Neuroimmunol, 94, 74, 10.1016/S0165-5728(98)00227-6 · DOI
- Wu, 2007, Relation of vision to global and regional brain MRI in multiple sclerosis, Neurology, 69, 2128, 10.1212/01.wnl.0000278387.15090.5a · DOI
Cited by
A lymphocyte–microglia–astrocyte axis in chronic active multiple sclerosis
Absinta, M., Maric, D., Gharagozloo, M., Garton, T., Smith, M. D., Jin, J., Fitzgerald, K. C., Song, A., Liu, P., Lin, J.-P., et al. (2021) · Nature · doi:10.1038/s41586-021-03892-7 · Cited by 768
Self-citationMultiple sclerosis progression: time for a new mechanism-driven framework
Kuhlmann, T., Moccia, M., Coetzee, T., Cohen, J. A., Correale, J., Graves, J., Marrie, R. A., Montalban, X., Yong, V. W., Thompson, A. J., et al. (2023) · The Lancet Neurology · doi:10.1016/s1474-4422(22)00289-7 · Cited by 667
Self-citationMechanisms underlying progression in multiple sclerosis
Absinta, M., Lassmann, H., & Trapp, B. D. (2020) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000818 · Cited by 175
“Of note, in a recent genome-wide association study, C3 gene variants have been associated to accelerated retinal thinning in multiple sclerosis [71].”
Therapeutic targeting of the complement system in ocular disease
Rathi, S., Hasan, R., Ueffing, M., & Clark, S. J. (2023) · Drug Discovery Today · doi:10.1016/j.drudis.2023.103757 · Cited by 24
Metadata
- Authors
- Fitzgerald, K. C., Kim, K., Smith, M. D., Aston, S. A., Fioravante, N., Rothman, A. M., Krieger, S., Cofield, S. S., Kimbrough, D. J., Bhargava, P., Saidha, S., Whartenby, K. A., Green, A. J., Mowry, E. M., Cutter, G. R., Lublin, F. D., Baranzini, S. E., De Jager, P. L., & Calabresi, P. A.
- Affiliations
- Department of Neurology, Johns Hopkins School of Medicine, Baltimore, MD, USA
- Department of Neurology, University of California San Francisco, San Francisco, CA, USA
- Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, USA
- Department of Biostatistics, University of Alabama at Birmingham, Birmingham, AL, USA
- Department of Neurology, Harvard Medical School, Boston, MA, USA
- Center for Translational and Computational Neuroimmunology, Department of Neurology, College of Physicians and Surgeons, Columbia University, New York, NY, USA
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2019-07-09
- Volume
- 142
- Issue
- 9
- Pages
- 2722-2736
- ISSN
- 0006-8950
- 1460-2156
- Cited by
- 49
- References
- 12
- Language
- en
- Funders
- National Institutes of Health
- NIH (R01NS082347, R01NS088155)
- National Multiple Sclerosis Society
- National Institute of Neurological Disorders and Stroke (UO1NS045719, R21NS41986, NCT00211887)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Early complement genes are associated with visual system degeneration in multiple sclerosis. https://app.cochat.ai/papers/10.1093/brain/awz188
- The paper
- Fitzgerald, K. C., Kim, K., Smith, M. D., Aston, S. A., Fioravante, N., Rothman, A. M., Krieger, S., Cofield, S. S., Kimbrough, D. J., Bhargava, P., Saidha, S., Whartenby, K. A., Green, A. J., Mowry, E. M., Cutter, G. R., Lublin, F. D., Baranzini, S. E., De Jager, P. L., & Calabresi, P. A. (2019). Early complement genes are associated with visual system degeneration in multiple sclerosis. Brain. https://doi.org/10.1093/brain/awz188
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.